SRNE - Sorrento Therapeutics, Inc.

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5190.37M
Enterprise Value 3141.19M
Trailing P/E N/A
Forward P/E 1-3.69
PEG Ratio (5 yr expected) 1-0.06
Price/Sales (ttm)12.05
Price/Book (mrq)1.79
Enterprise Value/Revenue 38.94
Enterprise Value/EBITDA 6-2.03

Financial Highlights

Fiscal Year
Fiscal Year Ends Dec 31, 2016
Most Recent Quarter (mrq)Jun 30, 2017
Profitability
Profit Margin -248.21%
Operating Margin (ttm)-471.26%
Management Effectiveness
Return on Assets (ttm)-12.64%
Return on Equity (ttm)-35.19%
Income Statement
Revenue (ttm)15.8M
Revenue Per Share (ttm)0.26
Quarterly Revenue Growth (yoy)417.20%
Gross Profit (ttm)7.34M
EBITDA -69.49M
Net Income Avi to Common (ttm)-39.22M
Diluted EPS (ttm)-0.66
Quarterly Earnings Growth (yoy)N/A
Balance Sheet
Total Cash (mrq)54.34M
Total Cash Per Share (mrq)0.79
Total Debt (mrq)26.54M
Total Debt/Equity (mrq)27.59
Current Ratio (mrq)0.76
Book Value Per Share (mrq)1.34
Cash Flow Statement
Operating Cash Flow (ttm)-80.23M
Levered Free Cash Flow (ttm)-19.38M

Trading Information

Stock Price History
Beta 1.99
52-Week Change 3-60.16%
S&P500 52-Week Change 317.47%
52 Week High 36.25
52 Week Low 31.50
50-Day Moving Average 32.52
200-Day Moving Average 31.98
Share Statistics
Avg Vol (3 month) 31.14M
Avg Vol (10 day) 3805.67k
Shares Outstanding 579.32M
Float 43.73M
% Held by Insiders 145.76%
% Held by Institutions 113.25%
Shares Short 33M
Short Ratio 34.99
Short % of Float 35.41%
Shares Short (prior month) 32.93M
Dividends & Splits
Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 4N/A
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 21/25
Last Split Date 3Aug 1, 2013